XOMA completes acquisition of Turnstone Biologics for $0.34 cash plus CVR per share

XOMA Royalty Corp

XOMA accepted 17,192,002 shares (~74% of outstanding) at $0.34 plus one CVR per share.
Merger completed under Section 251(h) of DGCL; no stockholder vote held.
Outstanding shares not tendered converted to $0.34 and one CVR; options cancelled for no consideration.
CVR Agreement dated Aug 11, 2025, with Broadridge as rights agent.

item 2.01item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.